Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Discover various ways to increase your cash back rewards and enhance your overall savings strategy. Start maximizing your benefits now!
23,199 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
Ripple's price failed to clear a midline resistance, prompting renewed debate on whether XRP will break out or resume...
A heated public dispute over tariffs erupts after a Supreme Court ruling on emergency tariffs, with Treasury Secretar...
Ethereum rebounds from a mid-$1,700s slip, but the rebound sits at a critical crossroad. The question: is this a reli...
Bitcoin staged a rapid reversal after a sharp drop tied to Middle East tensions, rebounding into the high 60,000s as ...
A circulating XRPL proposal aims to build a dedicated sidechain for exchange-grade options trading, linking it back t...
Oil markets are dictating Bitcoin moves as geopolitical risk deepens, outpacing CPI and ETF factors. Traders say the ...
A coalition pairing HBCUs with fintech and civil rights groups frames AI as the most important civil human issue of o...
A veteran executive coach shows how Beat the Plan helps Fortune 500 leaders cut decision time, improve quality, and s...
PIPPIN tumbled 45% in 24 hours, shaving roughly $200 million off its market cap as leveraged bets collapsed and trade...
A new security study shows post-hack damage outpaces the initial theft. In 2026, projects confront funding cuts, dela...